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The HSV-1 VP5 and VP16 transcripts are expressed with leaky-late (g1) kinetics and reach maximal levels after viral DNA
replication. While the minimal VP5 promoter includes only an Sp1 site at 248, a TATA box at 230, and an initiator (Inr) element
at the cap site, here we show that elements upstream of 248 can functionally compensate for the mutational loss of the
critical Sp1 site at 248. To determine whether this is a general feature of leaky-late promoters, we have carried out a detailed
analysis of the VP16 promoter in the context of the viral genome at the gC locus. Sequence analysis suggests a great deal
of similarity between the two. Despite this, however, mutational analysis revealed that the 59 boundary of the VP16 promoter
extends to ca. 290. This region includes an Sp1 binding site at 246, CAAT box homology at 277, and “E box” (CACGTG) at
285. Mutational and deletional analyses demonstrate that the proximal Sp1 site plays little or no role in promoter strength;
despite this it can be shown to bind Sp1 protein using DNA mobility shift assays. Like the VP5 promoter, the VP16 promoter
also requires an initiator element at the cap site. The VP16 Inr element differs in sequence from that of the VP5 promoter,
and its deletion or mutation has a significantly smaller effect on promoter strength. The difference between these two Inr
elements was confirmed by our finding that the VP16 initiator element binds to the 65-kDa YY1 transcription factor, and the
VP5 Inr element competes poorly for the binding between the VP16 element and infected cell proteins in comparative
bandshift assays. While the VP16 Inr sequence is identical to that of several murine TATA-less promoters, the VP16 Inr
requires a TATA box for measurable activity. © 2000 Academic PressINTRODUCTION
Regulated gene expression during the productive rep-
lication cycle of herpes simplex virus type 1 (HSV-1) has
been extensively reviewed (Wagner, 1999; Wagner et al.,
1998; Jameson et al., 1998; Hay and Ruyechan, 1992).
Viral proteins furnishing the functions necessary for viral
gene expression, replication, and viral assembly are ex-
pressed in a coordinated and sequential manner. Two
groups, the immediate-early or a proteins required for
ctivating the expression viral genes and the early or b
proteins involved genome replication reach their maxi-
mum abundance prior to high levels of viral DNA repli-
cation (Daksis and Preston, 1992; Everett, 1984; Jameson
et al., 1998; Wagner et al., 1995). As this occurs, the
elative abundance of these early proteins declines and
ate proteins predominate. Many late proteins are in-
olved in virus morphogenesis and maturation. These,
oo, can be divided into two subclasses: leaky-late (g1)
and strict-late (g2). While the maximal expression of late
genes is dependent upon viral DNA replication, the g1
group is expressed at appreciable levels prior to the
initiation or in the absence of viral DNA synthesis while
the g2 group is readily detectable only upon such syn-
thesis. Thus, expressions of this latter class of proteins
are particularly sensitive to inhibitors of DNA replication1 To whom correspondence and reprint requests should be ad-
ressed. Fax: (949) 824-8551. E-mail: ewagner@uci.edu.
191(Huang and Wagner, 1994; Homa et al., 1991; Guzowski
and Wagner, 1993).
Much of the control of expression of these various
classes of viral proteins is at the level of transcription,
and we and others have demonstrated that both the
kinetics and the levels of expression of a particular
transcript encoding each viral protein are dictated by
features of the promoter controlling that transcript
(Huang and Wagner, 1994; DeLuca and Schaffer, 1985;
McGeoch, 1991; Dennis and Smiley, 1984). The functional
architectures of early and late promoters have been
carefully characterized, and, while they share some of
the general features with the majority of eukaryotic pol II
promoters, they clearly differ from each other (Corden et
al., 1980; Fantino et al., 1992; McKnight and Kingsbury,
1982; McKnight and Tjian, 1986). Indeed, a TATA box
located between 225 and 230 relative to the cap site is
the most constant defining feature of HSV promoters. Its
sequence and position relative to the cap site and other
cis-acting elements are intimately involved in controlling
the levels, but not kinetics, of transcription (Homa et al.,
1988; Homa et al., 1986; Flanagan et al., 1991; Pande et
al., 1998).
Early and late promoters also contain other cis-acting
elements involved in interaction with cellular transcrip-
tional machinery, but the arrangement and exact nature
of these elements differ markedly in a class-specific way.
Early promoter architecture is characterized by the pres-
ence of one or more sequence motifs binding cellular
0042-6822/00 $35.00
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192 LIEU AND WAGNERtranscription factors (such as Sp1, CAAT, and Hinf-P)
upstream of the TATA box. With the exception of the
repressive strong ICP4 binding site in some immediate-
early promoters, there are no cis-acting elements down-
stream of the TATA box. In contrast, late promoters share
a requirement for an initiator (Inr) element at the cap site
(Mavromara-Nazos and Roizman, 1989; Pande et al.,
1998; Huang and Wagner, 1994; Huang et al., 1993).
The two subclasses of late promoters also differ mark-
edly. A number of g2 promoters require no elements
pstream of the TATA box, but contain an element lo-
ated 20 to 30 bases downstream of the cap site. Re-
ently, we showed that this downstream activation se-
uence or DAS is involved in stabilization of the preini-
iation complex mediated by DNA–protein interactions
Petroski and Wagner, 1998). In contrast, our studies on
he VP5 promoter and the studies of others on the gE and
B promoters indicate that g1 promoters require tran-
scription factor binding sites upstream of the TATA box in
addition to an Inr sequence (Guzowski et al., 1994;
uang and Wagner, 1994; Sethna and Weir, 1993).
In this paper, we extended our studies by performing a
horough structural comparison between the VP5 pro-
oter and that controlling expression of another g1
ene, VP16. We have previously shown that critical ele-
ents of the VP5 promoter extend only from the Inr
lement through an Sp1 site at 248 (Huang et al., 1993;
uang and Wagner, 1994). Despite this, sequence anal-
sis shows that this promoter is rich in cis-acting ele-
ents further upstream including Sp1 binding sites at
144, 2208, and 2268; a CAAT binding site at 2111;
nd a YY1 factor binding site at 278. In this report, we
how that elements upstream of 248 can functionally
ompensate for the mutational loss of the critical Sp1
ite at 248.
Sequence analysis of the VP16 promoter suggests a
reat deal of similarity with the VP5 promoter in terms of
he arrangement of transcription factor binding sites (in-
luding Sp1 sites at 2133, 2123, and 246). Despite such
imilarities, mutational and deletional analyses in the
ontext of the viral genome at the gC locus revealed that
one of the Sp1 sites are required for promoter activity,
nd the 59 boundary of the VP16 promoter extends to ca.
100. The essential region includes a CAAT box homol-
gy at 277 and an “E box” (CACGTG; Kiermaier et al.,
999; Roy et al., 1997; Luo and Sawadogo, 1996) at 285.
his latter site has the potential to bind a number of
issue-specific regulatory factors including USF (Kier-
aier et al., 1999; North et al., 1999; Roy et al., 1997; Luo
nd Sawadogo, 1996). Some other cis-acting feature of
he promoter lying between this E-box and the Sp1 site at
46 is also important for full activity, but there is no
bvious transcription factor binding site homology within
t. As noted, the Sp1 site at 246 contributes minimally to
romoter activity, and, like the VP5 promoter, the VP16
romoter requires an initiator element at the cap site;
f
powever, they differ in both sequence and contribution to
romoter strength. The difference between these two Inr
lements was confirmed by our finding that the VP16
nitiator element binds to the 65-kDa YY1 transcription
actor. In contrast, we have previously demonstrated that
he VP5 initiator element binds to a 35-kDa cellular pro-
ein (Huang et al., 1996).
Thus, while our results confirm our model that g1
romoters have architectural features distinct from both
arly and strict-late promoters, they also reveal consid-
rable variation within this class. While the biological
ignificance of the differences in late promoter architec-
ure is not entirely clear, knowledge of the range of
ossible variations within a given kinetic class-specific
rchitectural arrangement is important in understanding
his and in designing useful vectors and viral reagents
or introducing genes into specific tissues.
RESULTS
he VP5 promoter contains both core and redundant
lements
We previously determined that despite the richness in
he cis-acting elements of the VP5 promoter (shown in
ig. 1), the only critical elements required for full pro-
oter expression are the Sp1 site at 248, the TATA box
t 230, and the Inr element at the cap site (Huang et al.,
993; Huang and Wagner, 1994). Mutations of the Sp1
ite at 248 in the context of the truncated promoter result
n a major reduction in promoter activity (Fig. 1, lane iii).
owever, when the mutated Sp1 site at 248 was put in
he context of the upstream YY1 site at 278 or the CAAT
ox at 2111, promoter activity of both recombinant vi-
uses was essentially the same as that of the full-length
romoter (Fig. 1, lanes v and vi). Representative experi-
ents are shown in Fig. 1, as are quantified results of
everal replicated determinations. This result demon-
trates that cis-acting elements upstream can compen-
ate for the loss of the downstream Sp1 site at 248 and
hat this promoter displays a high degree of redundancy
n sequence elements.
unctional architecture of the VP16 promoter
The VP16 transcript is expressed with leaky-late kinet-
cs—equivalent to the kinetics of expression of the VP5
ranscript. A survey of recognizable cis-acting elements
n the VP16 promoter is shown in Fig. 2A and demon-
trates a cap site located 30 bp downstream of a TATA
omology region (230 TTAAAT-25) (Blair et al., 1987), a
umber of potential Sp1 binding sites, a CAAT box, and
n E box (CACGTG). In order to assess functional simi-
arities between the promoters controlling these two
ranscripts, we carried out an extensive study of the
unctional architecture of the VP16 promoter. Specific
romoter alterations are shown in Fig. 2A, as are quan-
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193LEAKY-LATE HSV-1 PROMOTER ELEMENTStified measures of relative activity in expressing reporter
b-galactosidase mRNA in recombinant viruses. These
numbers are based upon a minimum of three replicate
experiments.
Deletion analysis
We first generated nested deletions to establish the 39
and 59 limits of the contiguous promoter. The 39 extent of
the promoter was determined in the context of a pro-
moter extending to 2276. Deletions to 195, 132, and 16
were generated and then inserted 59 of the reporter
b-galactosidase gene and recombined into virus as de-
scribed under Materials and Methods. Duplicate, inde-
pendent isolates were tested for each construct. Each
recombinant virus was used to infect rabbit skin cells,
and infected cell mRNA was isolated at 7 h postinfection.
Typical results are shown in Fig. 2B. The expression of
FIG. 1. The effect of mutation of the critical Sp1 site at 248 on VP5
representation of potential cis-acting VP5 promoter elements upstrea
xtends only to 248. Relative activity of the VP5 promoter within the con
nd is compared to that of a truncated promoter containing only 48 ba
t 248 was mutated in the context of various amounts of upstream seq
er virus isolate using PhosphoImager analysis as described under
mutant, the Sp1 site at 248 was changed from 248-GGGGTGGGGCGG
was changed to 248 GGGGaGGttCGG-37. (Bottom) Representative pri
with a m.o.i. of 5 PFU/cell, total RNA was isolated at 7 h postinfectio
xpression detected with a primer binding within the b-galactosidase
ontrol.reporter b-galactosidase mRNA was measured by
rimer extension with a reporter-specific primer. Deletion
e
bf leader sequences to 16 had no effect on expression
lanes i to iii); this demonstrated that there was no ele-
ent downstream of 16 important for the activity of this
romoter.
We similarly defined the 59 extent of the VP16 pro-
oter. Since deletion analysis demonstrated that this
romoter extends no further than 16, all upstream dele-
ions were analyzed in a reporter extending to 16, rela-
ive to the cap site. The various promoter deletions con-
rolling the reporter b-galactosidase gene were recom-
ined into the HSV genome and expression was
easured by analysis of reporter RNA levels again at 7 h
ostinfection. Deletion to 2100 had no significant effect
n reporter expression (Fig. 2B, lane vii), but a deletion to
82 resulted in a reproducible decrease in reporter
RNA levels to about 60% of control levels (lane v). This
egion contains a canonical E box (CACGTG) (Kiermaier
ter activity in the context of upstream elements. (Top) The schematic
e cap site is shown. Despite these elements, the minimal promoter
64 bases upstream and 63 bases downstream of the cap site is shown
stream of the cap site. The activity of promoters in which the Sp1 site
s also shown. Values are based on a minimum of three determinations
ls and Methods. Values are 620% of those shown. In the truncated
48 GGGGTGGttCGG-37. In the 286 and 2137 mutants, the sequence
tension experiments are shown. Rabbit skin fibroblasts were infected
10 mg of RNA was analyzed by primer extension. VP5 reporter gene
was compared to expression of wt VP16 transcripts used as internalpromo
m of th
text of 3
ses up
uence i
Materia
-37 to 2
mer ex
n, andt al., 1999; Roy et al., 1997; Luo and Sawadogo, 1996)
etween 290 and 285.
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195LEAKY-LATE HSV-1 PROMOTER ELEMENTSDeletion of sequences between 282 and 252 re-
ulted in a further threefold drop in reporter gene expres-
ion (lanes xii and xiii). Survey of the sequence between
82 and 252 (59-GGAGCCAATGTGGGGGGAAGTCAC-
AGGTA-39) revealed no readily recognizable transcrip-
ion factor binding site downstream of the CAT box.
urprisingly, deletion of the Sp1 site at 246 causing a
runcation to 234 resulted in no significantly greater loss
f activity (not shown). Such results suggest that the
P16 promoter contains a minimum of two separate
is-acting elements upstream of the TATA box. It is no-
able that, unlike the situation with the VP5 promoter, the
utative Sp1 site at 246 is not sufficient for full promoter
ctivity.
utational analysis of cis-acting elements upstream
f the VP16 promoter
We next used mutational analysis to investigate
hether the putative cis-acting elements upstream of the
inimal core had any role in the function of the subject
romoter. Representative data are again shown in Fig.
B and summarized in Fig. 2A. We altered the promoter
equence between 251 and 238 from 59-GGGGCGGC-
GTGCG-39 to 59-GctgcaGCCagaCG-39 and inserted the
utant sequence into the context of the VP16 promoter
xtending from 2276 to 16 to construct a reporter virus,
nd reporter RNA was measured by primer extension
nalysis. The recombinant virus exhibited the same level
f reporter gene expression as that of the wild-type
equence (lane ix). Thus, the function of this Sp1 site has
o measurable role in promoter activity whether sites
urther upstream are present or not. Again, and as ex-
ected from our deletion studies, mutations of two po-
ential Sp1 binding sites at 2123 and 2133 from 59-
CTGGGTGGCGGTGGGGTGGGGTT-39 to 59-ACTG-
cagctgGTGatccGGGGTT-39 in the context of wt
equences downstream had only a minimal effect on
romoter activity (lane x).
We also mutated the CAAT box sequence from 279 to
70 (59-AGCCAATGTG-39 to 59-AGaagcaGTG-39) in the
ontext of a VP16 promoter extending to 282. Reporter
ene expression was essentially equivalent to that seen
ith the unmodified deletion to 282 (compare lanes v
nd vi). This indicates that the difference in activity be-
FIG. 2. The functional extent of the VP16 promoter. (A) Promoter ele
ext are shown here. Relative activity of the VP16 promoter within the
hown and compared to that of modified promoters shown. Values
hosphoImager analysis as described under Materials and Methods. V
changing 251-GGGGCGGCCGTGCG-38 to 251-GCTGCAGCCAGACG
2135-ACTGGGTGGCGGTGGGGTGGGGTT-113 to 2135-ACTGCAGCTG
inserted between 215 and 29. This results in changing 215-CGAC
24-TGTCATTC14 to 24-TAGTGCGTC14, alteration of the TATA box ch
extension analyses. (Top) Reporter gene expression; (bottom) products with pri
in lanes i, ii, iii, and xv indicate the correct size for the extension product.ween the wt and 282 promoters is a result of the loss of
the E box.
One possible reason for the lack of observable effect
of the Sp1 sites identified by sequence was that they are
not functional. Therefore we investigated whether these
sites did, indeed, bind authentic Sp1. We used DNA
bandshift assays with purified epitope-tagged Sp1 and
with commercial HeLa nuclear extracts and Sp1 antibody
for this study. Oligonucleotides corresponding to se-
quences from 261 to 233 or 2138 to 2111 containing wt
or mutant Sp1 sites were incubated with commercial
Sp1. Data shown in Fig. 3A demonstrate that both oligo-
nucleotides containing the wt sites were efficiently
bound (lanes i and iv), but mutation of the Sp1 binding
motifs in these oligonucleotides sites reduced binding to
undetectable levels (lanes ii and iii). We used a commer-
cial HeLa cell extract and antiserum to Sp1 to further
examine the relative binding of the two Sp1 motifs be-
tween 2133 and 2123 (Fig. 3B). Again, oligonucleotides
containing wt elements bound Sp1 efficiently (lanes ii
and iv), and mutation of the site at 246 or 2133 reduced
this binding markedly (lanes i and iii). In contrast, muta-
tion of the site at 2123 had a less marked effect upon
binding (lane v). The presence of the antibody markedly
supershifted the complex binding to the Sp1 sites at
2133/2123 (lane viii). Again, no binding was seen when
the site at 2133 was mutated (lane vii), but some binding
remained upon mutation of the site at 2123 (lane ix). A
similar supershift was observed with the antibody and
the oligonucleotide containing the Sp1 site at 246 (not
shown).
Mutational analysis of the VP16 cap sequences
As discussed in the Introduction, where studied, HSV
promoters active at high levels following genome repli-
cation feature a cis-acting Inr-like element at or near the
transcript start site. We used mutational and deletion
analyses to demonstrate that the initiator of the VP16
promoter also has a significant role in its activity (results
quantitated in Fig. 2A). Essentially, the 39 VP16 promoter
cap sequence was deleted to 215. This was then used
for insertion of a linker and wt or mutated cap sequences
were then built back into the promoter. Modified promot-
ers were then tested for activity in recombinant reporter
predicted from sequence analysis and modifications described in the
t of 276 bases upstream and 95 bases downstream of the cap site is
sed on a minimum of three determinations per virus isolate using
are 620% of those shown. Mutation of the Sp1 site at 246 came from
tation of the Sp1 sites at 2133 and 2123 was done by changing
CCGGGGTT-113. The cap site deletion mutant contains an AvaI linker
-7 to 215-CTCCCCCGG-7. Alteration of the Inr sequence changed
230-TTAAATGC-23 to 230-TCGAGTGC-23. (B) Representative primerments
contex
are ba
alues
-38. Mu
GGGAT
CACGG
angedmers for wt VP16 or gD transcripts used as internal control. The arrows
f
C
t
t
p
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196 LIEU AND WAGNERvirus. Primer extension analysis of reporter RNA isolated
from cells at 7 h postinfection demonstrated that a full
deletion or an alteration of the cap sequences between
24 and 14 from 59-TGTCATTC-39 to 59-TGgtAcTC-39 re-
duced activity by approximately 40% (lanes xv to xviii).
The DNA sequence around the VP16 transcript start
site is identical to the Inr elements of the murine
terminal deoxynucleotidyltransferase (TdT) and ribo-
nucleotide reductase promoters (22-TCATTC13), and
is quite similar to that of the adenovirus major late
promoter (AdML; 22-TCACT13). Both murine promot-
ers lack a consensus TATA element, and the initiator
has been shown to be able to mediate transcription by
direct interaction with the TFIID preinitiation complex
(Smale and Baltimore, 1989; Kong et al., 1999; Johan-
sson et al., 1995). Accordingly, we wanted to determine
whether the VP16 initiator could function in the ab-
sence of the TATA box. We altered the VP16 promoter
sequence between 230 and 223 from 59-TTA-
FIG. 3. Demonstration of Sp1 binding to identified sites in the VP
double-stranded oligonucleotides containing Sp1 sites in the VP16 prom
wt Sp1 sites at 246 (see the legend to Fig. 2) in the context of 261 to 2
containing the Sp1 sites at 2123 and 2133 (2133/2123 or a mutation
2. Material that did not enter the gel is seen in the wells at the top of the
Kit (purchased from Geneka Biotechnology, Inc.) were incubated with
oligonucleotides corresponding to the mutant and wt Sp1 sites at 246,
containing the Sp1 sites at 2123 and 2133 (2133/2123 or a mutation
Sp1 site supplied by the manufacturer. Lanes vii, viii, and ix contain th
the anti-Sp1 antiserum supplied in the kit.AATGC-39 to 59-TcgAgTGC-39 and generated reporter
recombinant viruses. Mutation of the TATA alone or in
t
mthe presence of a mutated Inr sequence in the context
of 2276 resulted in undetectable reporter gene ex-
pression (Figs. 2A and 2B, lanes xx and xxi).
The VP16 Inr specifically interacts with a cellular
protein
We next investigated specific interactions between
uninfected and infected cell proteins and the VP16 Inr
element by competitive gel shift analysis (Fig. 4). When
32P-labeled dsDNA probe containing the VP16 sequence
rom 215 to 16 (59-CTCCCCCGGGCTGTCATTCCTC-
GGGG-39) was incubated with uninfected nuclear ex-
racts, a single major DNA–protein complex was de-
ected. Addition of increasing amounts of unlabeled
robe DNA demonstrated full competition (lanes marked
Self mock”), suggesting a specific interaction. Incuba-
ion of labeled probe with infected cell extracts gave a
ore complex pattern with three complexes readily de-
moter. (A) Commercial purified Sp1 was incubated with 32P-labeled
anes i and ii contain oligonucleotides corresponding to the mutant and
nes iii and iv are oligonucleotides with sequences from 2138 to 2111
3 (m-133/2123). The actual sequences are shown in the legend to Fig.
) Sp1 containing HeLa nuclear extracts and Sp1 antibody in the Nushift
me probes and fractionated on the same gel. Lanes i and ii contain
nes iii and iv are oligonucleotides with sequences from 2138 to 2111
3 (m-133/2123). Lane vi (Std) contains oligonucleotides containing an
nd mutant Sp1 sites in the 2138 to 2111 oligonucleotides as well as16 pro
oter. L
33. La
at 213
gel. (B
the sa
and la
at 213ectable. In these extracts, however, only the complex
igrating with the same rate as that seen in uninfected
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197LEAKY-LATE HSV-1 PROMOTER ELEMENTSextracts was efficiently competed with an excess of self-
unlabeled probe (“Self Inf”).
Further evidence of specific interaction was seen by
inefficient competition for binding with unlabeled ds oli-
gonucleotides with sequence corresponding to the mu-
tated Inr element shown above to reduce promoter ac-
tivity (“mInr mock” and “mInr Inf”). Significantly, the inef-
ficient competition was especially notable in the infected
cell extracts. In addition, unlabeled ds oligonucleotides
with sequences corresponding to the wt VP5 Inr extend-
ing from 211 to 115 (59-GATCCCCCGGGTCTGTTGGG-
ACACT-39) competed as poorly as the wt VP16 Inr
equence (“VP5Inr Inf”). The unlabeled ds oligonucleo-
ide containing the Sp1 binding site (59-ATTC-
ATCGGGGCGGGGCGAGC-39) did not compete at all
or binding when used as an unlabeled competitor (Sp1
ock).
he VP16 initiator element interacts with YY1 protein
The VP16 initiator element contains a putative binding
ite for YY1 (“CATT”), and we wanted to determine
hether the YY1 protein binds to this site. We utilized
32P-end-labeled probes containing the VP16 Inr from 215
o 16 with purified GST–YY1 fusion protein in another
lectromobility shift assay shown in Fig. 5. The ability of
his protein to bind YY1 containing DNA has been re-
orted elsewhere (Bennett et al., 1999). The results indi-
ate that the recombinant YY1 protein binds to the wt
P16 Inr fragment (lane i) and failed to bind to the mutant
P16 Inr or VP5 Inr (lanes ii and iii).
DISCUSSION
FIG. 4. Electrophoretic mobility shift assay of the binding of VP1
HSV-1-infected rabbit skin fibroblasts were obtained as described u
double-stranded oligonucleotides of the VP16 promoter extending acro
performed with unlabeled wt VP16 probe, the mutated VP16 initiator ele
xtending across 211 (59-GATCCCCCGGGTCTGTTGGGGACACT-39) 11
lanking bases (59-ATTCGATCGGGGCGGGGCGAGC-39).The first important observation reported here is that
hile the core cis-acting elements of the VP5 and VP16
t
Gromoters can be readily defined by deletion analysis,
utation of a critical VP5 promoter core element in the
ontext of the upstream elements results in little observ-
lement to cellular proteins. Nuclear extracts from mock-infected or
aterials and Methods. Extracts were incubated with the 32P-labeled
5 (59-CTCCCCCGGGCTGTCATTCCTCCGGGG-39)16. Competition was
15 (59-CTCCCCCGGGCTAGTGCGTCTCCGGGG-39)16, the VP5 probe
double-stranded oligonucleotide containing the canonical Sp1 site and
FIG. 5. Electrophoretic mobility shift assay of the VP16 promoter Inr
incubated with purified GST–YY1 fusion protein. Samples of 50 ng of
GST–YY1 fusion protein (obtained from Dr. Tim Osborne (Bennett et al.,
999)) were incubated with the 32P-labeled double-stranded oligonu-
cleotides of the VP16 promoter extending over 215 (59-CTC-
CCCCGGGCTGTCATTCCTCCGGGG39)16, the mutated VP16 initiator
element 215 (59-CTCCCCCGGGCTAGTGCGTCTCCGGGG-39)16, or6 Inr e
nder M
ss 21
ment 2he VP5 promoter extending across 211 (59-GATCCCCCGGGTCTGTT-
GGGACACT-39)115.
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198 LIEU AND WAGNERable effect. This is an important, if generally unrecog-
nized, consideration in assessing the functional extent of
promoters in the context of the viral genome. For exam-
ple, linker-scanning mutagenesis of the gE promoter has
been interpreted as demonstrating that no cis-acting
elements upstream of the TATA box are required (Sethna
nd Weir, 1993), but such results ignore the possible
resence of other cis-acting elements compensating for
he mutated site(s). Clearly, both mutation and deletion
ust be used to fully characterize any specific promoter.
The VP16 and VP5 promoters share similarities in
equence along with striking differences in functional
rchitecture. A major difference between the two promot-
rs studied can be found in the extent and nature of the
ore promoter elements identified. The deletion survey of
he 59 extent of the VP16 promoter summarized in Fig. 2
emonstrates the requirement for sequences up to
100. We were surprised that the VP16 promoter con-
ained functional Sp1 sites that had no role in measured
romoter activity and that there is at least one, as yet
nidentified, element between the E box (CACGTG) and
he Sp1 site at 246 that contributes significantly to pro-
oter activity. It is clear that the lack of function of the
p1 sites in the Vp16 promoter is not due to any func-
ional lack of transcription factor. This follows from the
act that we have previously shown that functional Sp1 is
resent in extracts of cells late after infection by HSV-1
Huang and Wagner, 1994). It was shown there and here
hat the Vp5 promoter requires an Sp1 site for full activity
ate after infection; this underscores the presence and
vailability of functional transcription factor. The E box
etween 285 and 290 in the VP16 promoter is the first
ocumentation of its functional occurrence in an HSV-1
romoter. This motif is found in numerous promoters
ncluding those occurring in HIV LTR and Epstein–Barr
irus ED-L2 early lytic cycle promoter (Jenkins et al.,
997; Suzuki et al., 1999; Moriuchi et al., 1999). Proteins
inding to E boxes such as upstream stimulating factors,
ruppel-like factors, basic helix-loop-helix proteins, ke-
atinocyte-specific factors, and the HTLV-1 Tax protein
ave been shown to have tissue-specific regulatory
oles. A number of reports have also shown that this
lement has a role in tissue-specific promoter expres-
ion. Such tissue includes skeletal muscles, squamous
pithelial cells, and nerve cells (Esser et al., 1999;
heeler et al., 1999; North et al., 1999; Moriuchi et al.,
999; Suzuki et al., 1999; Jenkins et al., 1997; Athanikar
nd Osborne, 1998). It will be interesting to determine
hether the element has any role in HSV’s ability to
eplicate in various tissues.
The presence of an Inr element in the VP16 promoter
s expected from its general occurrence in late promot-
rs, but the VP16 Inr sequence (25-GCTGTCATTCC15)
iffers markedly from that of the VP5 Inr (25-
CCGGGTCTGT15). Such differences are also con-
irmed by the fact that the VP16 Inr binds to the cellular
irotein YY1, while the VP5 Inr does not. Again the func-
ional contributions of the elements are significantly dif-
erent. Loss of the VP16 Inr results in about 40% of
aximal activity (Fig. 2), and we observed that this con-
ribution to overall activity was the same at 3 h as at late
imes (data not shown). Thus, the VP16 Inr appears to
ave little influence on the overall kinetics of expression
f this transcript. In contrast, alteration of the Inrs of the
P5 and several other late HSV promoters has at least a
ivefold effect on late promoter activity (Huang et al.,
993, 1996; Woerner and Weir, 1998; Huang and Wagner,
994; Steffy and Weir, 1991). Also, in the case of the VP5
romoter, the effect of loss of the Inr on activity at early
imes is significantly less, which has the result of oper-
tionally converting this promoter to a weak early pro-
oter. This suggests that the roles of the Inr elements in
he two promoters differ mechanistically.
A major feature of the VP16 Inr is the presence of the
Y1 binding site. While it has been shown that YY1
rotein binds to several late HSV-1 promoters, including
he VP5 and gD upstream of the TATA box (Mills et al.,
994), this is the first report of its occurrence near an
SV initiator element; thus, it was important to confirm
hat YY1 actually binds the VP16 Inr. This interest was
ntensified by the varied effects this protein is known to
ave on transcription. YY1 is a multifunction protein that
an take part in repression or activation of transcription,
epending on the promoter context and other factors
resent. It has been shown to interact with a number of
egulatory proteins: TBP, TFIIB, Sp1, TAFII55, and E1A
Bushmeyer et al., 1995; Thomas and Seto, 1999; Usheva
nd Shenk, 1996; Seto et al., 1991). Margolis et al. (1994)
eported that YY1 recognizes the initiator region of the
IV-1 LTR and decreased LTR-directed gene expression.
xpression of YY1 protein with an HIV-1 clone resulted in
ecreased virus production in vivo. In contrast, the ade-
ovirus E1A protein can alter YY1 activity so that instead
f functioning as a repressor in the AdML promoter, its
inding activates transcription (Bushmeyer et al., 1995;
eto et al., 1991). Further, YY1 typically represses the
deno-associated virus P5 promoter, but in the presence
f E1A protein, it can be converted into a potent tran-
criptional activator. Seto et al. (1993) have shown that
he YY1 protein can bind to the adeno-associated virus
ype 2 P5 promoter initiator region and mediate transcrip-
ion through an initiator element in vitro. Subsequently,
sheva and Shenk (1996) demonstrated that YY1 inter-
cts with TFIIB and RNA pol II and supports basal tran-
cription from supercoiled plasmid templates in vitro, in
he presence of TFIIB and RNA pol II alone. It will be of
nterest in the future to study the role that the YY1 protein
lays in regulating HSV-1 viral gene expression. It will be
f interest to determine whether ICP4, an essential pro-
ein required for activating HSV gene expression, can
nteract with YY1 and influence its function.
The VP16 Inr sequence (25gctgTCATTCc15) shares a
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199LEAKY-LATE HSV-1 PROMOTER ELEMENTShexanucleotide sequence with the murine TdT and ribo-
nucleotide reductase R1 Inr elements (25acgTCATTC-
gaa15). Both mouse promoters lack a consensus TATA
box, but we found that mutations of the VP16 TATA box in
the presence of the wt Inr sequences resulted in unde-
tectable reporter gene expression. Thus, unlike the TATA-
less promoters, the VP16 Inr requires a functional TATA
box to mediate transcription. The requirement for a TATA
box has been shown to be the mechanism of ICP4-
mediated transcriptional activation (Gu and DeLuca,
1994; Carrozza and DeLuca, 1998; Imbalzano and De-
Luca, 1992; Kuddus et al., 1995; DeLuca and Schaffer,
1988). Since the HSV transcriptional activator ICP4 inter-
acts with both TBP and TAFII250, the relative contribution
f binding of different proteins at the initiator element
ay account for the quantitative difference in the contri-
ution of the VP16 Inr to full promoter strength compared
o that of the VP5 Inr. Thus, defining the exact elements
nd proteins binding to these sites is important in un-
erstanding the mechanisms of HSV-1 gene regulation.
In conclusion, the superficial similarities between the
P16 and VP5 promoters in the arrangement of Sp1
inding sites are so marked as to suggest a common
rigin, but clearly their functional role in promoter activity
as not been conserved. While the data presented in this
aper describe the situation at a time late after infection
ince the promoter attains maximum activity then, we
ave determined that the specifics of functional architec-
ure and their differences are seen at early times also
data not shown). These differences and the presence of
otentially redundant elements fully underscore the need
or complete functional analysis of any HSV promoter
efore it is operationally grouped with others. We have
ecently shown that the VP16 promoter can functionally
ubstitute for the VP5 promoter controlling expression of
he major capsid protein at its wt locus in the viral
enome as assayed by virus replication in cultured cells
Lieu and Wagner, 2000). It will be of interest to measure
he effect of such a substitution on the pathogenesis
nd/or tissue-specific expression of this protein in ani-
als. The differences between these promoters, and
specially the fact that the VP16 promoter contains a
utative tissue-specific transcription factor binding site,
einforce this interest.
MATERIALS AND METHODS
ells
Rabbit skin fibroblasts and Vero cells were maintained
t 37°C under 5% carbon dioxide in Eagle’s minimum
ssential medium containing 5% cadet calf serum, 100 U
f penicillin, and 100 mg of streptomycin per milliliter.
Virus
1The wild-type HSV-1 strain 17 syn was used to gen-
rate recombinant viruses containing the modified VP5nd VP16 promoter in the gC locus using our standard
ethods described in detail elsewhere and outlined be-
ow (Lieu et al., 2000; Wagner et al., 1998; Guzowski et al.,
994; Huang and Wagner, 1994; Huang et al., 1993).
utations of the VP5 promoter elements
Mutations of the Sp1 site at 248 were generated in the
ontext of the VP5 promoter containing sequences from
48 to 163, 279 (containing the YY1 site) to 163, and
133 (containing both YY1 and the CAAT box) to 163,
riving the expression of the bacterial b-galactosidase
gene. Plasmids pCH204, pCH203, and pCH207 de-
scribed in Huang et al. (1993) and Huang and Wagner
1994) were digested with XbaI and Asp718 restriction
nzymes, and the resulting fragments containing the
arious VP5 promoter regions and part of the b-galacto-
sidase gene were cloned into a pAlter-1 Vector, from the
commercial Altered Sites II Mutagenesis Systems (Pro-
mega).
An oligonucleotide containing the mutations of the Sp1
site at 248, GGGG(T.a)GG(GG.tt)CGGGG, along with
the ampicillin repair oligonucleotide was annealed to the
single-stranded DNA template. The mutant promoters
were synthesized by T4 DNA polymerase and ligated
with T4 DNA ligase using procedures described in detail
in the supplier’s (Promega) technical manual. The result-
ing plasmids containing the mutated Sp1 at 248 were
digested with XbaI and Asp718 and cloned into the gC
recombination cassette to generate recombinant vi-
ruses.
Generation of VP16 promoter/leader deletions
We started with a cloned VP16 promoter fragment
extending from 2276 to 1153 relative to the cap site and
containing an XbaI linker at the 59 end described in Blair
et al. (1987). This corresponds to bases 105,533 to
105,258 of the 17 syn1 genome (McGeoch, 1991). This
lone was digested with XbaI at 2276 and EcoRV at
1153 and subcloned into pUC20. This plasmid was lin-
earized with EcoRV and subjected to digestion with
Bal31 exonuclease from IBI (Sambrook et al., 1989). Fol-
lowing digestion, phage T4 DNA polymerase (Boehringer
Mannheim) was used to blunt DNA ends and HindIII
linkers were ligated. Plasmids were ligated together and
transformed in Escherichia coli DH5a. Various leader
lengths generated were 195, 132, and 16. These were
igested with XbaI and HindIII and subcloned into the
indIII site upstream of the reporter bacterial b-galacto-
sidase gene in the gC recombination cassette described
elsewhere (Huang et al., 1993; Guzowski and Wagner,
1993; Guzowski et al., 1994).
Generation of the 59 deletions of the VP16 promoter
was performed by polymerase chain reaction with spe-
cific oligonucleotides. The VP16 promoter sequence ex-
tending from 2276 to 16 in conjunction with the 59 213
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200 LIEU AND WAGNERbases of the b-galactosidase reporter gene was sub-
cloned into pGEM3 as an XbaI–Asp718 fragment. The
upstream primers for PCR were single-stranded oligonu-
cleotides with an XbaI linker and 20 bases of the pro-
moter sequence starting from 234, 246, 252, 286,
100, and 2136, relative to the transcription start site.
he downstream primer binds in the 59 213 bases of the
b-galactosidase sequence overlapping the Asp718 site.
This was used to generate deletions by the standard
PCR methods: 94°C for 1 min, 55°C for 1 min, 72°C for 1
min for 45 cycles, followed by a final extension at 72°C
for 10 min. The PCR products were extracted with phe-
nol–chloroform and deposited by ethanol precipitation.
The resuspended material was then digested with XbaI
and Asp718 and separated by agarose gel electrophore-
sis. The appropriate size fragments were eluted and
cloned into the pGEM3 vector. After the ends and se-
quences were confirmed, they were cloned back into the
gC recombination vector as XbaI–Asp718 fragments.
Mutation of VP16 promoter elements
The sequences of all mutated elements are shown
under Results and in the appropriate figure legends. The
Sp1 site near 246 was mutated as follows. The VP16
promoter sequence extending from 2276 to 16 fused
upstream of the bacterial b-galactosidase gene de-
scribed above was digested with XbaI and Asp718 and
subcloned into the p-Altered-1 Vector (Promega), and
mutagenesis was performed using a commercial Altered
Sites II Mutagenesis Kit (Promega). A mutagenic oligo-
nucleotide containing the mutated Sp1 site at 246 was
annealed to the VP16 promoter, and the mutant promoter
was synthesized by T4 DNA polymerase and ligated with
T4 DNA ligase using procedures described in detail in
the supplier’s (Promega) technical manual.
Construction of the mutated Sp1 sites from 2123 to
133 and the CAAT box at 277 utilized oligonucleotide-
irected mutagenesis by PCR. Plasmids containing the
P16 promoter sequence beginning at 2133 and 286
ere subcloned as XbaI–Asp718 fragments into pGEM3
ector. Single-stranded oligonucleotides containing the
utated CAAT box at 277 and mutated Sp1 sites from
123 to 2133, along with the lower strand of the oligo-
ucleotide to the b-galactosidade sequence, were used
to generate mutations by PCR as described in the pre-
ceding section. The PCR products were cloned into the
pGEM3 vector and sequenced to confirm the mutations
and to ensure that no new mutations were introduced
before cloning back into the gC recombination cassette.
Mutations in the VP16 Inr region were generated as
follows. The VP16 promoter containing the sequence
from 2276 to 16 in conjunction with part of the b-galac-
tosidase gene was subcloned into pGEM3. This plasmid
was digested with HindIII at 16 and shortened from 16
to 215 by using Bal31 deletion. An AvaI linker was addedto the deletion end-points. The wt cap sequences were
built back from 215 by ligating the double-stranded oli-
onucleotides containing sequences from 215 to 16
ith the 59 AvaI linker and a 39 HindIII linker. Similarly,
he mutated cap sequences were generated by ligating
he double-stranded oligonucleotides containing the mu-
ated cap sequence 215 (59-CTCCCCCGGGCTAGT-
CGTCTCCGGGG-39)16. These constructs were se-
uenced with the SP6 primer.
Construction of mutated TATA and Inr elements utilized
he commercially available Quick Change Site-Directed
utagenesis Kit from Stratagene. The VP16 promoter
ontaining sequences from 2276 to 16 and the 59 region
f the b-galactosidase gene described above was sub-
cloned into pGEM3 at the XbaI and Asp718 sites. The
mutagenic oligonucleotide containing the mutated TATA
sequence or both mutated TATA and Inr elements was
annealed to the VP16 promoter. The mutant promoter
was synthesized by PCR with reagents and enzymes
from the kit following the detailed methods described in
the Strategene manual. Mutations were confirmed by
sequencing.
DNA mobility shift assays
Rabbit skin cells were mock-infected or infected with
HSV-1 at a multiplicity of infection (m.o.i.) of 5 PFU per
cell. After a 1-h adsorption period, infection was allowed
to proceed for 7 h, and nuclear extracts were prepared
as described in Huang and Wagner (1994), Guzowski et
al. (1994), and Lee et al. (1988). Electrophoretic mobility
shift assays with DNA probes were carried out by stan-
dard methods (Chodosh, 1989; Guzowski et al., 1994).
ach assay contained 2 mg of nuclear extract, 0.2 ng of
32P-labeled DNA fragment, and 2 mg of poly(dI:dC) in a
total volume of 10 ml. The binding reactions were allowed
to proceed for 30 min at room temperature and com-
plexes were detected by electrophoresis conducted at
200 V for approximately 2 h at 4°C on 4.5% polyacryl-
amide gels. For competition experiments, the unlabeled
oligonucleotides were added in a 10- to 250-fold molar
excess of the radiolabeled DNA probe prior to incubation
with nuclear extracts.
Gel shift assays with GST–YY1 fusion protein were
performed with probes containing wt VP16 Inr, mutant
VP16 Inr, and VP5 Inr described below. Each assay con-
tained 50 ng of GST–YY1 fusion protein (obtained from
Dr. T. Osborne), 0.2 ng of 32P-labeled DNA fragment, 50
ng of dIdC, 20% Ficol, 5 ml of Z9 buffer (Bennett et al.,
1999), and 1 ml of 5 mg/ml nonfat milk incubated for 20
min on wet ice. Following the incubation, 2 ml of loading
dye (0.1% bromphenol blue, 0.1% xylene cyanol) was
added to each sample. The samples were run on a 4.5%
nondenaturing polyacrylamide gel in 0.223 TBE at 450 V
at 4°C. The gels were then dried and subjected to auto-
radiography at 70°C with an intensifying screen.
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201LEAKY-LATE HSV-1 PROMOTER ELEMENTSElectrophorectic mobility shift assays were also per-
formed with the HeLa nuclear extracts and Sp1 antibody
(the Nushift Kit, purchased from Geneka Biotechnology,
Inc.) and purified Sp1 extracts obtained from Promega.
Assays were carried out with ds oligonucleotides de-
scribed below: the VP16 promoter sequences from 2138
to 2111, containing two potential Sp1 binding sites at
2123 and 2133; mutations at 2123 (m123) or mutations
at 2133 (m133), and oligonucleotides spanning se-
quences from 261 to 233, containing the potential Sp1
site at 246. For supershift analysis, 2 ml of the Sp1
ntibodies was added to HeLa nuclear extract prior to
he addition of labeled probes. Reaction protocols are
escribed in detail in the manuals of the Nushift Kit from
eneka Biotechnology, Inc. and the gel shift assay sys-
em from Promega.
NA oligonucleotide probes
A ds oligonucleotide containing the VP16 promoter
rom 215 to 16 (59-CTCCCCCGGGCTGTCATTCCTC-
GGGG-39) was used as the probe for VP16 DNA mobil-
ty shift assays. A ds oligonucleotide extending from 211
o 115 relative to the VP5 cap site was used in the
ompetition assays. The single-stranded oligonucleo-
ides were end-labeled with T4 polynucleotide kinase
nd [g-32P]ATP and then annealed. The competing ds
ligonucleotides used were the mutated VP16 cap se-
uences 215 (59-CTCCCCCGGGCTAGTGCGTCTC-
GGGG-39)16, the VP5 Inr 211 (59-GATCCCCCGGGTCT-
TTGGGGACACT-39)115, and the canconical Sp1 site
59-ATTCGATCGGGGCGGGGCGAGC-39). The ds oligo-
ucleotides for HeLa nuclear shift and Sp1 antibody
ssays were as follows: sequences from 261 to 233
CACGAGGTACGGGGCGGCCGTGCGGGT) of the VP16
romoter containing the potential Sp1 binding site at
46; mutations at 246 (CACGAGGTACGCTGCAGCCGT-
CGGGT); sequences from 2138 to 211 (CCGTGACT-
GGTGGCGGGGGGTGGGTTGGACA) containing two
otential Sp1 sites at 2123 and 2133; mutations at
133m (CCGTGACTGCAGTTCTGCGGGTGGGTTGGACA);
nd mutations at 2123m (CCGTGACTGGGTGGCGGG-
ATCGTATTGGACA).
eneration and analysis of recombinant viruses using
he gC recombination cassette
The gC recombination cassette described previously
Singh and Wagner, 1995; Wagner et al., 1998) was used
s the vector to introduce modifications of the VP16
romoter in the viral genome at the gC locus. Promoter
nd leader constructs were cloned into the gC recombi-
ation vector as XbaI–Asp718 cassettes. Plasmids were
igested with SalI to release HSV-specific sequences
1nd cotransfected with infectious HSV-1 17 syn DNA
into a monolayer of rabbit skin fibroblasts by the CaPO4precipitation method (Wagner et al., 1998; Goodart et al.,
1992; Bludau and Freese, 1991).
Recombinant viruses were isolated by limiting dilution
and screened on both rabbit skin fibroblasts and Vero
cells as described in Guzowski and Wagner (1993). Two
independent isolates from separate transfections were
generated to ensure that both exhibit equivalent levels of
b-galactosidase expression. Pure isolates were ana-
lyzed by PCR and the promoter regions were sequenced
using the Sequenase kit (U.S. Biochemical) as described
elsewhere (Huang et al., 1993; Guzowski et al., 1994;
Guzowski and Wagner, 1993).
RNA isolation and primer extension analysis
Rabbit skin fibroblasts were infected with recombinant
viruses at a m.o.i. of 5 PFU per cell. Infections were
allowed to proceed for 7 h, and total RNA was isolated
using the Trizol Reagent (Gibco BRL). Primer extension
analysis was carried out with 10 mg of total RNA with 10
fmol of 32P-labeled primers. A primer extending from 48
ases in the b-galactosidase gene was used to detect
reporter gene expression for the VP5 and VP16 promoter
in the gC locus (Huang and Wagner, 1994; Guzowski et
al., 1994). Primers specific for VP16 wt and gD transcripts
ere used as internal controls, which give rise to the
6-nt band and 85-nt doublet band, respectively.
All primer extension signals were visualized by scan-
ing a PhosphoImager screen (Molecular Dynamics) and
uantified by using IP Lab Gel software (Signal Analysis
orp.) as described (Lieu et al., 2000).
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